Based on a recommendation by another SGS Maine Pointe client, a generic pharmaceutical company asked for help in growing their ability to meet savings goals, become competitive on a global scale, and reach CA$1 billion in revenue. They had fallen short of savings targets for several years, a situation exacerbated by supply chain disruptions, cyber attacks, and other market headwinds.
To compete internationally, they were anxious to capture all the opportunities available to save costs and keep prices low for patients. They had also expanded their original site and opened a second site and were rethinking their organization.
In addition, they had to decide whether they would continue to depend on third-party manufacturers or should make their products in-house, especially for a new product they were introducing in competition with China.
SGS Maine Pointe: